. Author manuscript; available in PMC: 2010 Apr 13.

Published in final edited form as: Am J Gastroenterol. 2009 Apr 21;104(6):1406–1411. doi: 10.1038/ajg.2009.103

Table 3. SLC4A2 haplotype structure and analysis: PBC patients vs. controls.

	SNP												Frequency		P-additive (P =0.913)^a	P-dominant (P =0.775)^a	P-recessive (P =0.707)^a
#	1	2	3	4	5	6	7	8	9	10	11	12	PBC	Control	P-additive (P =0.913)^a	P-dominant (P =0.775)^a	P-recessive (P =0.707)^a
1	C	G	G	A	C	G	C	G	C	G	G	C	0.283	0.316	0.182	0.076	0.897

2	C	G	A	G	C	G	C	A	C	G	G	C	0.160	0.155	0.687	0.843	0.450

3	T	A	A	A	C	G	T	G	C	A	A	C	0.131	0.127	0.893	0.987	0.613

4	C	G	A	A	C	A	C	A	C	A	G	T	0.127	0.115	0.523	0.657	0.275

5	T	A	A	A	C	G	C	G	C	A	A	C	0.051	0.047	0.655	0.673	NA

6	C	G	G	A	C	G	C	A	C	G	G	C	0.039	0.045	0.807	0.819	NA

7	C	G	A	A	C	A	C	A	C	G	G	C	0.038	0.034	0.727	0.830	NA

8	T	G	A	A	C	A	C	A	C	A	G	T	0.032	0.028	0.953	0.957	NA

9	T	A	A	A	T	G	T	G	C	A	A	C	0.030	0.027	0.619	0.639	NA

10	C	G	A	A	C	G	T	G	T	A	A	C	0.023	0.028	0.572	0.597	NA

NA, not applicable; PBC, primary biliary cirrhosis; SNP, single nucleotide polymorphism.

Global P-value under the specified model.